Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Clinical and Translational Medicine|December 30, 2020
CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-κB oncogenic signalingBo Hu, Yang Xu, Yuan-Cheng Li, et al.
Journal of Cancer|November 3, 2021
Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinomaFei Song, Fei-Yu Chen, Sui-Yi Wu, et al.
Frontiers in Cellular and Infection Microbiology|July 5, 2022
Metagenomic Next-Generation Sequencing Versus Traditional Laboratory Methods for the Diagnosis and Treatment of Infection in Liver TransplantationJun-Feng Huang, Qing Miao, Jian-Wen Cheng, et al.
Ebiomedicine|November 12, 2020
Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinomaKai-Qian Zhou, Yun-Fan Sun, Jian-Wen Cheng, et al.
Clinical and Translational Medicine|July 24, 2020
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched studyPeng-Xiang Wang, Yun-Fan Sun, Kai-Qian Zhou, et al.
Cell Death & Disease|October 12, 2018
BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathwaysXu-Xiao Chen, Yue Yin, Jian-Wen Cheng, et al.
Cancer Cytopathology|June 6, 2020
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resectionYun-Fan Sun, Peng-Xiang Wang, Jian-Wen Cheng, et al.
Clinical and Translational Medicine|August 2, 2024
Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8<sup>+</sup> T-cell infiltration in hepatocellular carcinomaFei Song, Bo Hu, Xiao-Liang Liang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2020
Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantationPeng-Xiang Wang, Yang Xu, Yun-Fan Sun, et al.
Hepatology (Baltimore, Md.)|August 20, 2025
Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolutionKai-Qian Zhou, Yu-Chen Zhong, Min-Fang Song, et al.
Pageof 7